Strong UltraFLEXplus Demand Recognized, but Valuation and Margin Concerns Persist

What happened

Zacks highlights surging demand for Teradyne's UltraFLEXplus testers driven by AI, emphasizing competitive strength against KLA and Cohu. The DeepValue master report confirms strong fundamentals: Q2 2026 revenue of $1.329B, memory revenue above $200M for the third consecutive quarter, and supportive AI capex signals. However, the stock trades at 49.6x P/E and 73.8x EV/EBITDA, pricing in durable AI test demand with little margin of safety. Q3 guidance of $1.20B-$1.30B implies a 5.9% sequential decline, and Q2 operating margin fell to 32.9% from 36.9% in Q1, signaling mix and timing headwinds. The master report rates TER a WAIT, suggesting better entry below $315 or evidence of margin recovery above 35%.

Implication

The bullish case rests on sustained AI-driven tester demand and continued memory revenue above $200M, with upstream capex from TSMC, Microsoft, and Amazon remaining strong. However, customer concentration and order timing create elevated risk of digestion pauses, and Q3 guidance already points to a sequential revenue decline. The stock's premium multiple leaves limited room for error; any disappointment in Semiconductor Test or memory revenue could trigger a sharp de-rating. Investors should focus on execution metrics: Semiconductor Test must hold near record levels, memory revenue must stay above $200M, and operating margin must recover above 35% to justify the valuation. Until one of these conditions is met or the stock pulls back to the $315 attractive entry zone, the risk/reward is unfavorable for new positions.

Thesis delta

The new article does not materially change the thesis; it reinforces known demand strength but omits valuation and margin concerns. The existing WAIT rating remains appropriate, as the article's positive framing is already reflected in the stock price. No change to conviction; monitoring triggers remain as previously defined.